<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240501061615N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-08-26</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of an oil product containing essential oils of two plants and oregano on treatment-resistant head lice</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effect of Topical  Herbal Product Based on Olive Oil and Dietary Recommendations Based on Persian Medical Resources in Patients with Resistant Head Lice Treatment</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-09-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77598</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Eligible people are randomly assigned to the groups under study (the herbal product consuming group, the herbal product consuming group with dietary recommendations, and the control group) in a simple random manner and in a ratio of 1:1:1. The randomization process will be done using the online computerized random allocation sequence and through the dedicated website of the randomization process. Allocation of individuals/patients (Randomization) to the groups under study will be hidden for the patient, physician/interventionist, and outcome assessor (allocation concealment). In this way, the belonging of the people to the groups under study is marked on the paper/card and placed inside the opaque envelopes so that its contents cannot be seen from the outside. During the visit of the eligible patient for the study, the attending physician takes one of the envelopes and then opens it, and based on the contents of the envelope, the patient is placed in the intervention 1, intervention 2 or comparison/control group and treatment services are provided, Blinding description: Evaluators and analysts will be unaware of the intervention and control groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Pediculus humanus capitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1:An oily herbal product containing the essential oils of two plants, Myrtus and oregano, will be taken topically three times at intervals of seven days. The hair is completely impregnated with the product and massaged for ten minutes, then covered with a hair cap for 2 hours, and then washed and dried with shampoo, and at the end of each treatment, an examination is done in terms of contamination and its severity. Intervention 2: Intervention group2: In addition to the oily herbal product prescribed in the first group, dietary recommendations based on traditional medicine sources were received in writing, according to the recommendations of Traditional Iranian Medicine, dietary recommendations provided to patients include avoiding the consumption of fast food, sausages, pasta, salads, high-fat foods, figs and berries, salads and yogurt with meals, consumption of liquids with and after meals, eating and Eating beef and veal during the treatment period and the examinations are the same as the first group. Intervention 3: Control group: The control group or the group that is considered as the standard group in this study is the people who will take Dimethicone 4% lotion twice with an interval of seven days. Apply dimethicone lotion to dry hair, from root to tip, then allow it to dry naturally, the lotion should be left on the head for at least 8 hours or overnight, then rinsed thoroughly with water and shampoo.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mirshahi Afsaneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Iranian and Complementary Medicine Clinic, Amlam Reza Research and Therapeutic Hospital, Ibn Sina St</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3854 3031</telephone>
        <email>mirshahia5@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Salari Roshanak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Dr. Kharazmi Educational Complex, University Campus,East Gate of Ferdowsi University of Mashhad ،Azadi Square,</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177899191</zip>
        <telephone>+98 51 3884 8930</telephone>
        <email>SalariR@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female children with head lice who have not improved with two consecutive courses of treatment 
Parents' willingness to cooperate in the plan  
Insensitivity to plant essential oils 
Accessibility during research      
Age 6 to 12 years old
No history of asthma, allergies and skin allergies according to the parents' report 
Absence of chronic skin disease</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Allergy history
Reluctance to cooperate
Allergy to oregano and myrtle</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B85.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pediculosis due to Pediculus humanus capitis                                                                                              Head-louse infestation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1:An oily herbal product containing the essential oils of two plants, Myrtus and oregano, will be taken topically three times at intervals of seven days. The hair is completely impregnated with the product and massaged for ten minutes, then covered with a hair cap for 2 hours, and then washed and dried with shampoo, and at the end of each treatment, an examination is done in terms of contamination and its severity.</i_keyword>
      <i_keyword>Intervention group2: In addition to the oily herbal product prescribed in the first group, dietary recommendations based on traditional medicine sources were received in writing, according to the recommendations of Traditional Iranian Medicine, dietary recommendations provided to patients include avoiding the consumption of fast food, sausages, pasta, salads, high-fat foods, figs and berries, salads and yogurt with meals, consumption of liquids with and after meals, eating and Eating beef and veal during the treatment period and the examinations are the same as the first group.</i_keyword>
      <i_keyword>Control group: The control group or the group that is considered as the standard group in this study is the people who will take Dimethicone 4% lotion twice with an interval of seven days. Apply dimethicone lotion to dry hair, from root to tip, then allow it to dry naturally, the lotion should be left on the head for at least 8 hours or overnight, then rinsed thoroughly with water and shampoo.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The rate of complete recovery based on examination, visual visit, observation of the intention or adult lice and a questionnaire to determine the severity of the infestation. Timepoint: Examinations are generally performed 4 times upon arrival and on days 7, 14 and 21. Method of measurement: The rate of complete recovery based on examination, visual visit, observation of the intention or adult lice and a questionnaire to determine the severity of the infestation.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Checking the severity of itching. Timepoint: Examinations are generally performed 4 times on arrival and on days 7, 14 and 21. Method of measurement: By completing the questionnaire.</sec_outcome>
      <sec_outcome>Examination of dryness in order to check complications. Timepoint: Examinations are generally performed 4 times on arrival and on days 7, 14 and 21. Method of measurement: By completing the questionnaire.</sec_outcome>
      <sec_outcome>Check for redness to check for complications. Timepoint: Examinations are generally performed 4 times on arrival and on days 7, 14 and 21. Method of measurement: By completing the questionnaire.</sec_outcome>
      <sec_outcome>Examination of skin irritation in order to investigate complications. Timepoint: Examinations are generally performed 4 times on arrival and on days 7, 14 and 21. Method of measurement: By completing the questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-13</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Second floor, Research and Technology Vice-Chancellor, Building number one of Mashhad University of Medical Sciences (Qureshi), in front of Daneshgah 18, Daneshgah St. Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
